FDA authorizes first pill to treat COVID-19
The US Food and Drug Administration on Wednesday approved use of Pfizer's antiviral pill, Paxlovid, to treat COVID-19 in high-risk individuals 12 years of age and older who weigh at least 88 pounds.
CNN reports this as the first antiviral COVID-19 pill authorized for those who are ill to take at home, before they get sick enough to be hospitalized.
Pfizer Chairman and CEO Albert Bourla said in a statement, "Pfizer stands ready to begin delivery in the U.S. immediately to help get PAXLOVID into the hands of appropriate patients as quickly as possible."
Paxlovid combines a new antiviral drug named nirmatrelvir and an older one called ritonavir.
Last week, Pfizer announced that treatment with the new drug cuts the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms.
If given within the first five days of symptoms, the efficacy was similar: 88%.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Volunteer group works to clean up Capitol Lake and keep wildlife safe...
Local businesses kick off the holiday shopping season with Small Business Saturday
Possible tornado sweeps through St. Charles, Jefferson Parishes; nearly 5,500 without power...
Car submerged in canal after driver veered off I-12 near Essen Lane;...
Two hurt in apparent Black Friday gun battle between two vehicles on...
Southeastern hosting Idaho in first round of FCS Playoffs Saturday
Fans' Choice Award Winner: U-High's Keylan Moses
Southeastern running back Derrick Graham has a deep passion for rodeo
Southeastern to face Idaho in first round of FCS Playoffs
The Black and Gold Report: New Orleans Saints vs Los Angeles Rams